Dr Reddy’s Arm To Buy Haleon Plc’s NRT Business, Including Nicotinell

HYDERABAD: Pharma major Dr Reddy’s Laboratories is acquiring British consumer healthcare player Haleon Plc’s entire nicotine replacement therapy (NRT) business, outside of the United States market, for a consideration of GBP 500 million.

As part of the deal, Dr Reddy’s arm Dr Reddy’s Laboratories SA will be acquiring 100% stake in newly incorporated Haleon group company Northstar Switzerland SARL and has inked a definitive agreement for the same, it said in a regulatory filing.

The portfolio being acquired by the Hyderabad-based company includes Nicotinell, touted as the second biggest brand in the NRT space globally with a footprint in 31 countries across Europe, Latin America and Asia, including countries like Japan. Nicotinell is also branded as Nicabate in Australia, Thrive in Canada and Habitrol in New Zealand and Canada.

The deal includes an upfront payment of GBP 458 million as well as performance-based contingent payments of up to GBP 42 million that will be payable in 2025 and 2026.

Dr Reddy’s said the deal, which is expected to close in the fourth quarter of 2024 and is subject to satisfactory completion of customary conditions, including regulatory approvals, will give it access to a global OTC anchor brand that would be a potential vehicle for the company to to build its global consumer healthcare OTC business.

“The proposed acquisition will be inclusive of all formats such as lozenge, patch, gum as well as pipeline products in all the applicable global markets outside of the US,” Dr Reddy’s said.

The total revenue of the portfolio being acquired clocked net revenues of around 217 million pounds in 2023. The company has been stepping up its presence in the consumer healthcare markets globally, acquiring several brands such as Habitrol in the NRT space, pain relief brand Doan’s, women’s health products like Premama for fertility and parenthood, and MenoLabs portfolio for menopause.

“The intellectual property, business contracts, dossiers and other assets related to the portfolio being acquired will reside in Northstar Switzerland and its fully owned step-down subsidiaries North Star OpCo Ltd and North Star Sweden AB, to be incorporated in England and Wales and Sweden, respectively,” it said.

Related Posts

  • Pharma
  • November 1, 2024
  • 179 views
Delhi: Noida Police Arrested An Accused With Drugs Who Sold Fake Medicines On Diwali Day

New Delhi/Noida: A gang manufacturing fake medicines has been busted in Delhi-NCR. In this case, Noida’s Phase-3 police station arrested and accused. 94 fake vials, banned injections, drug mephentermine sulfate injections…

  • Pharma
  • November 1, 2024
  • 163 views
How Asian Pharma Suppliers Cash In On Ozempic Copies

SHANGHAI: Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro and Orsema, developed by a little-known Bangladeshi drugmaker, Incepta Pharmaceuticals. The injectable…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi: Noida Police Arrested An Accused With Drugs Who Sold Fake Medicines On Diwali Day

Delhi: Noida Police Arrested An Accused With Drugs Who Sold Fake Medicines On Diwali Day

How Asian Pharma Suppliers Cash In On Ozempic Copies

How Asian Pharma Suppliers Cash In On Ozempic Copies

ICMR Invites Expressions Of Interest For Non-Invasive Hemoglobinometer Validation

ICMR Invites Expressions Of Interest For Non-Invasive Hemoglobinometer Validation

Centre To Amend MDR To Include QMS Requirements For Certain Medical Devices

Centre To Amend MDR To Include QMS Requirements For Certain Medical Devices

Chocolates Mixed With Bhang Seized In Chhatrapati Sambhaji nagar, Seller Arrested

Chocolates Mixed With Bhang Seized In Chhatrapati Sambhaji nagar, Seller Arrested

In keeping with Nomenclature, Sparsh Hospital touched Lives of Teachers

In keeping with Nomenclature, Sparsh Hospital touched Lives of Teachers